Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U4atac small nuclear 13, pseudogene (RNU4ATAC13P)
- Target
- RNU4ATAC13P
- Molecular classification
- Pseudogene, Non-coding RNA, Small nuclear RNA (snRNA) pseudogene
01
Overview
RNA, U4atac small nuclear 13, pseudogene (RNU4ATAC13P) is an annotated pseudogene in the human genome. It is homologous to the functional U4atac small nuclear RNA (snRNA) genes, which are components of the minor spliceosome required for splicing U12-type introns from pre-mRNA. As a pseudogene, RNU4ATAC13P is generally considered non-functional: it does not encode a protein and there is no evidence for a stable or functional RNA product. While pseudogenes can sometimes be transcribed and participate in regulatory processes (e.g., as miRNA decoys or sources of small regulatory RNAs), there is no direct evidence that RNU4ATAC13P is active in such roles. It is not considered a therapeutic target or biomarker. RNU4ATAC13P is therefore best classified as a pseudogene of non-coding RNA origin, with no established therapeutic, diagnostic, or functional biological significance currently documented in the scientific literature.
- Other names
- RNU4ATAC13PU4atac small nuclear RNA 13 pseudogene
02
Mechanism of action
None (no evidence of being druggable or of interacting with small molecules or biologics)
03
Biological functions
No direct function as a protein or enzymeLike other pseudogenes, may participate in regulatory RNA processes such as acting as a potential RNA decoy or, if transcribed, may generate regulatory non-coding RNAs, short interfering RNAs (siRNAs), or microRNA decoysPotential involvement in post-transcriptional regulation, though not experimentally confirmed for this specific pseudogene
04
Disease associations
No direct rolePseudogenes (in general) can regulate gene expression and have emerging roles in diseases (such as acting as competing endogenous RNAs in cancer), but there is no evidence that RNU4ATAC13P specifically is involved in any disease mechanism
Beyond the preview
Go deeper on RNA, U4atac small nuclear 13, pseudogene (RNU4ATAC13P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U4atac small nuclear 13, pseudogene (RNU4ATAC13P).